Natriuretic peptides in heart valve disease

Heart

Volumn 92, Issue 9, 2006, Pages 1194-1197

  Ray, Simon ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

CLINICAL FEATURE; DISEASE SEVERITY; HEART FAILURE; HEART SURGERY; HUMAN; PRIORITY JOURNAL; REVIEW; VALVULAR HEART DISEASE;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; HEART VALVE DISEASES; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS;

EID: 33748048500     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.074161     Document Type: Review

References (30)

1. Rodeheffer RJ. Measuring plasma B-type natriuretic peptide in heart failure. J Am Coll Cardiol 2004;44:740-9.
2. Hall C. Essential biochemistry and physiology of (NT-proBNP). Eur J Heart Fail 2004;6:257-60.
3. Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 1998;274:H1684-9.
4. Bonow RO, Carabello B, de Leon AC Jr, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32:1486-588.
5. Enriquez-Sarano M, Avierinos J-F, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875-83.
6. Fukuda N, Shinohara H, Sakabe K, et al. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract. J Heart Valve Dis 2003;12:333-40.
7. Qi W, Mathisen P, Kjekhus J, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001;142:725-32.
8. Talwar S, Downie PF, Squire IB, et al. Plasma N-terminal pro BNP and cardiotropin-1 are elevated in aortic stenosis. Eur J Heart Fail 2001;3:15-9.
9. Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004;94:740-5.
10. Gerber IL, Stewart RAH, Legget ME, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003;107:1884-90.
11. Prasad N, Bridges A, Lang CC, et al. Brain natriuretic peptide concentrations in patients with aortic stenosis. Am Heart J 1997;133:477-9.
12. Vanderheyden M, Goethals M, Verstreken S, et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 2004;44:2349-54.
13. Ikeda T, Matsuda K, Itoh H, et al. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J 1997;133:307-14.
14. Qi W, Mathisen P, Kjekhus J, et al. The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis. Clin Cardiol 2002;25:174-80.
15. Lim P, Montin JL, Monchi M, et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 2004;25:2048-53.
16. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom free survival and postoperative outcome in severe aortic stenosis. Circulation 2004;109:2302-8.
17. Wiese S, Breyer T, Dragu A, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fibre length. Circulation 2000;102:3074-9.
18. Gerber IL, Leggett ME, West TM, et al. Usefulness of serial measurements of N-terminal pro-brain natriuretic peptide levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol 2005;95:898-901.
19. Berendes E, Schmidt C, Van Aken H, et al. A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg 2004;98:11-9.
20. Gerber IL, Stewart RAH, French JK, et al. Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation. Am J Cardiol 2003;92:755-8.
21. Eimer MJ, Ekery DL, Rigolin VH, et al. Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. Am J Cardiol 2004;94:676-8.
22. Tharaux PL, Dussaule JC, Hubert-Brierre J, et al. Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy. Clin Sci 1994;87:671-7.
23. Hung JS, Cherng WJ, Inoue K, et al. Rapid fall in elevated plasma atrial natriuretic peptide levels after successful catheter balloon valvuloplasty of mitral stenosis. Am Heart J 1989;117:381-5.
24. Nakamura M, Kawata Y, Yoshida H, et al. Relationship between plasma atrial and brain natriuretic peptide concentration and haemodynamic parameters during percutaneous transvenous mitral valvotomy in patients with mitral stenosis. Am Heart J 1992;124:1283-8.
25. Iivanainen AM, Tikkanen I, Tilvis R, et al. Associations between atrial natriuretic peptides, echocardiographic findings and mortality in an elderly population sample. J Intern Med 1997;241:261-8.
26. Talwar S, Squire IB, Davies JE, et al. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur Heart J 1999;20:1736-44.
27. Brookes CI, Kemp MW, Hooper J, et al. Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis 1997;6:608-12.
28. Sutton TM, Stewart RAH, Gerber IL, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003;41:2280-7.
29. Delaint D, Messika-Zeitoun D, Avierinos J-F, et al. B-type natriuretic peptide in organic mitral regurgitation. Circulation 2005;11:2391-7.
30. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005;26:1309-13.